Почетна страницаALC • SWX
add
Alcon AG
Прет. посл. цена
63,50 CHF
Дневен опсег
63,12 CHF - 63,50 CHF
Годишен опсег
57,68 CHF - 87,00 CHF
Пазарна капитализација
31,62 милј. CHF
Просечен обем
1,15 мил.
Сооднос Ц/З
38,08
Принос од дивиденда
0,44 %
Примарна берза
SWX
Во вестите
Информации
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Главен извршен директор
Основана на
1945
Седиште
Веб-сајт
Вработени
25.000